CD274 and non-small cell lung carcinoma: Studies of patients with metastatic NSCLC have demonstrated that higher incremental PD-L1 tumor proportion score (TPS) levels3–6 are associated with favorable outcomes with recent reports suggesting those with very high PD-L1 ( ≥ 90%) are a unique cohort with more durable disease control6,7.